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infiltration and microglia alterations
Patrick P. Lowe1, Caroline Morel2, Aditya Ambade1, Arvin Iracheta-Vellve1, Erica Kwiatkowski1,
Abhishek Satishchandran1, Istvan Furi1, Yeonhee Cho1,2, Benedek Gyongyosi1, Donna Catalano2, Eric Lefebvre3,
Laurent Fischer3, Star Seyedkazemi3, Dorothy P. Schafer4 and Gyongyi Szabo1,2*
Abstract
Background: Chronic alcohol consumption is associated with neuroinflammation, neuronal damage, and
behavioral alterations including addiction. Alcohol-induced neuroinflammation is characterized by increased
expression of proinflammatory cytokines (including TNFα, IL-1β, and CCL2) and microglial activation. We
hypothesized chronic alcohol consumption results in peripheral immune cell infiltration to the CNS. Since
chemotaxis through the CCL2-CCR2 signaling axis is critical for macrophage recruitment peripherally and centrally,
we further hypothesized that blockade of CCL2 signaling using the dual CCR2/5 inhibitor cenicriviroc (CVC) would
prevent alcohol-induced CNS infiltration of peripheral macrophages and alter the neuroinflammatory state in the
brain after chronic alcohol consumption.
Methods: C57BL/6J female mice were fed an isocaloric or 5% (v/v) ethanol Lieber DeCarli diet for 6 weeks. Some
mice received daily injections of CVC. Microglia and infiltrating macrophages were characterized and quantified
by flow cytometry and visualized using CX3CR1eGFP/+ CCR2RFP/+ reporter mice. The effect of ethanol and CVC
treatment on the expression of inflammatory genes was evaluated in various regions of the brain, using a
Nanostring nCounter inflammation panel. Microglia activation was analyzed by immunofluorescence. CVC-treated
and untreated mice were presented with the two-bottle choice test.
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Results: Chronic alcohol consumption induced microglia activation and peripheral macrophage infiltration in the
CNS, particularly in the hippocampus. Treatment with CVC abrogated ethanol-induced recruitment of peripheral
macrophages and partially reversed microglia activation. Furthermore, the expression of proinflammatory markers
was upregulated by chronic alcohol consumption in various regions of the brain, including the cortex,
hippocampus, and cerebellum. Inhibition of CCR2/5 decreased alcohol-mediated expression of inflammatory
markers. Finally, microglia function was impaired by chronic alcohol consumption and restored by CVC treatment.
CVC treatment did not change the ethanol consumption or preference of mice in the two-bottle choice test.
Conclusions: Together, our data establish that chronic alcohol consumption promotes the recruitment of
peripheral macrophages into the CNS and microglia alterations through the CCR2/5 axis. Therefore, further
exploration of the CCR2/5 axis as a modulator of neuroinflammation may offer a potential therapeutic approach for
the treatment of alcohol-associated neuroinflammation.
Keywords: Macrophage, Microglia, Alcohol, Neuroinflammation, Cytokines
Introduction
Alcohol use disorder (AUD) impacts millions of people
across the world, including at least 17 million US pa-
tients [1]. Nearly 100,000 patients die each year because
of AUD [1], which induces organ injury throughout the
body, including in the liver and in the brain. In both
humans and mice, alcohol intoxication leads to central
nervous system (CNS) inflammation and neurodegenera-
tion [2–4]. Recent studies using animal models have
shown that inflammatory signaling not only contributes
to neurodegeneration but also to alcohol addiction [5–
7], making targeting of neuroinflammation a critical ap-
proach in the treatment of AUD.
Both infiltrating macrophages (IMs) and microglia be-
come activated in response to tissue damage and can re-
lease proinflammatory cytokines, which may contribute to
neuroinflammation and blood-brain barrier breakdown [8,
9]. Further, microglia, a resident macrophage of the CNS,
become activated in the brain after alcohol use [8, 9]. In
addition to microglia, peripheral macrophages can be re-
cruited into the CNS under pathologic conditions and
may serve to amplify ongoing neuroinflammation [10]. Re-
cent evidence suggests that breakdown of the blood-brain
barrier occurs in postmortem tissue of AUD patients, and
knockout of Toll-like receptor 4 (TLR4), an important in-
nate immune signaling receptor expressed by microglia
and peripheral macrophages, protects from the ensuing
alcohol-induced neuroinflammation [11]. While microglial
activation has been studied in alcohol-induced neuroin-
flammation, the potential infiltration of peripherally re-
cruited macrophages is yet to be evaluated.
Peripheral macrophage chemotaxis through the
receptor-ligand CCR2-CCL2 signaling axis is important in
macrophage recruitment to the CNS. Recent studies have
found an increase in the expression of the CCR2 ligand,
CCL2 (also called monocyte chemoattractant protein 1;
MCP1), in the brain after chronic alcohol consumption [8,
12, 13]. Cenicriviroc (CVC) is a small molecule inhibitor
recently developed to block signaling through CCR2, as
well as the chemokine receptor CCR5 that recognizes
CCL5 and is involved in the recruitment of monocytes
and T cells [14]. CVC is currently under investigation in a
phase 3 trial to treat liver fibrosis in non-alcoholic steato-
hepatitis (NCT03028740), a disease that involves signifi-
cant inflammation [15]. CVC has been shown previously
to inhibit macrophage recruitment and activation in liver
disease [16].
We hypothesized that, because the chemokine CCL2 is
highly expressed in human and mouse brains after
chronic alcohol use, chronic ethanol promotes infiltra-
tion of peripheral IM recruitment in the brain, those
IMs contribute to ethanol-induced neuroinflammation,
and treatment with CVC to inhibit infiltration of periph-
eral macrophages will protect from proinflammatory sig-
naling in the CNS. Here, we present evidence of region-
specific peripheral macrophage recruitment, associated
with cytokine expression and microglial activation after
exposure to a model of chronic alcohol in mice. Treat-
ment with CVC reduced the number of IMs in the CNS,
reduced cytokine expression, and corrected microglial
morphology.
These data provide important insights into the role of
IMs in alcohol-induced neuroinflammation and offer a
novel target for therapeutic treatment in this preclinical
model of alcohol use disorder.
Methods
Mice
The study protocol was approved by the Institutional
Animal Use and Care Committee of the University of
Massachusetts Medical School. All the methods were
carried out in accordance with the approved guidelines.
CX3CR1eGFP/eGFP mice were provided by Dr. Dorothy
Schafer from the University of Massachusetts Depart-
ment of Neurobiology. CCR2RFP/RFP mice were pur-
chased from the Jackson Labs. CX3CR1eGFP/wt
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CCR2RFP/wt mice were bred in-house. Wild-type mice
were purchased from the Jackson Labs and allowed to
acclimate to our animal medicine facility for at least 1
week prior to experimental use. Eight-week-old female
mice were used for alcohol feeding experiments. Eight-
week-old C57BL/6J mice were divided into alcohol- and
pair-fed (control) groups as well as two CVC alcohol-fed
groups. Alcohol-fed mice received 5% (v/v) alcohol in
Lieber-DeCarli liquid diet ad libitum as previously de-
scribed [17]. Pair-fed animals received a calorie-matched
liquid diet. Mice were provided continuous access to al-
cohol or calorie-matched liquid diet until the time of
anesthesia and were immediately transcardially perfused
once appropriate sedation was achieved.
CVC administration
Some alcohol-fed mice received daily subcutaneous in-
jections of 15 mg/kg body weight Cenicriviroc (CVC;
provided by Tobira Therapeutics, Delaware, USA) for 6
weeks (“prevention” cohort) while others received the
same dose daily for 3 weeks (beginning after 3 weeks of
alcohol feeding and continued to week 6 of alcohol feed-
ing; “treatment” cohort). Ten percent hydroxypropyl-β-
cyclodextrin (Sigma, St. Louis, MO USA), 5% Kolliphor
(solutol) HS15 (Sigma), and 85% sterile water were used
as a vehicle to dissolve CVC into a solution. Pair-fed
mice and alcohol-fed mice received daily injections of
the vehicle without CVC for 6 weeks.
Brain immune cell isolation
Mice were anesthetized and transcardially perfused with
PBS/heparin (Hospira, Lake Forest, IL, USA) to clear
blood cells from the vasculature. The brains were dis-
sected out and meninges removed. The tissue was then
homogenized with a Tenbroek homogenizer (Corning,
Corning, NY, USA), and the cell suspension was then
passed through a 70-μm filter. This single-cell
suspension was then applied to a 70/50/35% Percoll Plus
(GE Healthcare, Pittsburgh, PA, USA) density gradient
and spun at 2000g for 20–30min. Microglia and macro-
phages collected at the interphase were then washed
with PBS before proceeding.
Flow cytometry
Isolated immune cells were stained with the Live/Dead
Fixable Blue Dead Cell Stain Kit from Life Technologies
(Grand Island, NY, USA) to exclude dead cells. Anti-
mouse CD16/CD32 mAb from BD Biosciences (San Jose,
CA, USA) was used to block non-specific Fc receptor
binding and incubated for 20 min at 4 °C. Cells were im-
munostained for 30 min at 4 °C with surface antibodies
(Table 1), fixed and permeabilized with BD Biosciences
Cytofix Cytoperm Plus according to the manufacturer’s
protocol, and stained for intracellular CD68 for 30 min
at 4 °C (Table 1). Data were acquired on a BD Biosci-
ences LSR II instrument and analyzed using the FlowJo
v10.1 software (Ashland, OR, USA).
Tissue preparation and confocal microscopy
Mice were anesthetized and transcardially perfused with
PBS/heparin (Hospira, Lake Forest, IL, USA) to clear
blood cells from the vasculature. The brains were dis-
sected out and meninges removed and fixed in 4% para-
formaldehyde (Boston Bioproducts, Ashland, MA, USA)
for 3–4 h at room temperature then cryopreserved in
30% sucrose overnight at 4 °C. Tissue was then placed in
OCT Compound (Tissue Tek, Torrance, CA, USA) and
frozen at − 20 °C. Twelve to 14 μm sagittal sections were
cut using a Leica LM3050S cryostat (Buffalo Grove, IL,
USA). The tissue sections were washed with PBS,
blocked in 1% BSA (Fisher BioReagents, Fair Lawn, NJ,
USA) and 1% normal goat serum (Invitrogen, Carlsbad,
CA, USA) with 0.3% Triton X-100 (Sigma) at room
temperature for 2 h, stained overnight with the
Table 1 Flow cytometry and immunofluorescence antibodies
Antigen Color Clone Company Cat. no.
CD11b APC M1/70 Biolegend 101212
CD45 PE/Cy7 30-F11 eBioscience 25-0451-82
CD68 PerCP/Cy5.5 FA-11 Biolegend 137010
CD86 FITC
MHC-II APC/Cy7 M5/114.15.2 Biolegend 107628
CD206 PE C068C2 Biolegend 141706
CD163 (goat host) n/a K-18 Santa Cruz sc-18796
Goat IgG Qdot 525 n/a Invitrogen Q22072
Primary antigen Primary dilution Company Cat. no. Secondary and fluor Secondary dilution
IBA1 1:500 Wako Anti-Rb-488 1:500
CD68 1:500 AbD Serotec MCA1957 Anti-Rt-647 1:500
Secondary antibodies from Life Technologies
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appropriate primary antibodies (Table 1) at 4 °C, washed,
stained with appropriate secondary antibodies (Table 1)
for 1 h at room temperature, and mounted with Prolong
Gold Antifade Reagent (Invitrogen). Images were ac-
quired using either an LSM 700 scanning confocal
microscope with Zeiss Imager.Z2 or a Zeiss Observer.Z1
confocal microscope equipped with the Zen Blue acqui-
sition software (Zeiss, Oberkochen, Germany).
Analysis of microglial immunofluorescence
Microglia were identified within the hippocampus, and
soma area and the perimeter length of microglial exten-
sions were measured using Fiji v1.0. Somas were mea-
sured by drawing a circumferential outline along the
edge of the cell body to the base of any cellular exten-
sions. The perimeter length was measured by summing
the lengths of all cellular extensions.
RNA extraction and qPCR
Brain tissue was dissected from mice perfused with PBS/
heparin, and the hippocampus, cerebellum, and cortex
tissue were stored in RNA later. The cortex tissue was
defined as the superficial tissue (from the surface to ap-
proximately 0.5 mm deep) dissected approximately 2
mm anterior, 2 mm posterior, and 3 mm lateral with re-
spect to the bregma, a region that encompasses the
motor and somatosensory cortex. RNA was extracted
using the miRNeasy Kit (Qiagen, Germantown, MD,
USA) with on-column DNAse digestion (Zymo Re-
search, Irvine, CA). Concentration was determined using
a Nanodrop 2000 (Thermo Scientific, Waltham, MA,
USA), and 1 μg RNA was used for cDNA reverse tran-
scription (BioRad, Hercules, CA, USA). Quantitative
real-time polymerase chain reaction (qPCR) was com-
pleted using SYBR Green polymerase (BioRad) and ex-
pression measured on a BioRad CFX96 Real Time
System. qPCR primers are listed in Table 2, and the ex-
pression was quantified by using the 2−ΔΔCt method.
Nanostring gene expression analysis
RNA was extracted as above. RNA and Nanostring reac-
tions were prepared according to the manufacturer’s rec-
ommendation for the Mouse nCounter Inflammation
Panel (Nanostring Technologies, Seattle, WA, USA).
Data were analyzed using the nSolver Analysis Software
3.0 (Nanostring Technologies).
Two-bottle choice test
A continuous access (24 h access) two-bottle choice be-
tween alcohol and drinking water was used to measure
alcohol consumption [18]. Briefly, mice were housed sin-
gly and were provided two water-only graduated glass
feeders [19] for a 1-day acclimation period along with a
chow diet which was provided ad libitum throughout
the experiment. Thereafter, one feeder was filled with al-
cohol and the other water. Mice consecutively received 4
days each of 3, 6, 9, and 12% (v/v) alcohol in water. Al-
cohol was made fresh daily, and the alcohol feeder loca-
tion was changed to control for side preference bias.
Consumption volumes were measured daily and a con-
trol cage without mice was included on each mouse rack
to correct for spillage of liquid throughout the 24-h
period. In the event of leakage from a feeder or if cage
bedding was stuffed into the feeder by a mouse, data
from that cage for that day was excluded from the ana-
lysis. Alcohol consumption and preference were calcu-
lated as previously described [18]. Some wild-type
female C57BL/6J were treated with daily i.p. injections of
15 mg/kg body weight CVC or with an equal volume of
the vehicle.
Statistical analysis
Statistical significance was determined using Student t
test or ordinary one-way ANOVA with Tukey’s multiple
comparison post-test to compare the means of multiple
groups. Data are shown as mean ± SEM and were con-
sidered statistically significant at p < 0.05. For the two-
bottle choice test analysis, we used the two-way analysis
of variance (ANOVA) with post hoc Bonferroni with
GraphPad Prism 7.0c (GraphPad Software Inc., La Jolla,
CA, USA).
Results
Alcohol induces recruitment of peripheral macrophages
into the CNS
In order to investigate the role of peripheral infiltrating
macrophages (IMs) in chronic alcohol, we used a com-
mon model [20] of chronic alcohol consumption in mice
(Fig. 1a). We measured the mRNA expression of the
chemokine receptors Ccr2 and Ccr5 and the macrophage
chemokine Ccl2, a ligand for CCR2, in the CNS. Alcohol
significantly induced Ccl2, Ccr2, and Ccr5 expression
compared with pair-fed controls in both the cerebellum
and hippocampus (p < 0.05), but not in the cortex (Fig.
1b). To test if this upregulation of monocyte chemokines
and receptors is associated with the infiltration of macro-
phages, we next isolated CNS immune cells from the total
brain and examined the cells using flow cytometry. Per-
ipheral IMs were defined by flow cytometry as
CD11b+CD45hi cells to differentiate from CD11b+CD45lo
microglia (Fig. 1c). CD11b+CD45hi IMs were significantly
more abundant in alcohol-fed mice compared to pair-fed
mice (6.2 ± 0.52% vs 12.03 ± 1.64%, p < 0.01) (Fig. 1d).
These data suggested that peripheral immune cells indeed
infiltrate into the CNS after alcohol feeding and, based on
the differential expression of chemokine receptor and lig-
and, that they may be recruited to particular brain regions.
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To better understand the regional distribution of periph-
eral macrophages identified using flow cytometry from the
total brain, we crossed CX3CR1eGFP/eGFP and CCR2RFP/RFP
mice to yield CX3CR1eGFP/+ CCR2RFP/+ mice (Fig. 2a),
allowing for the differentiation of microglia (CX3CR1eGFP)
and IMs (CCR2RFP). CCR2RFP macrophages were identifi-
able in the cortex, cerebellum, and the hippocampus of
ethanol-fed mice (Fig. 2b). Although there was a general
trend toward an increase in the number of peripheral
CCR2RFP+ IMs after chronic alcohol in all three brain re-
gions, IMs were twice as numerous in the hippocampus in
the ethanol-fed mice (Fig. 2c). Interestingly, there was no
change in the number of CX3CR1eGFP/+ microglia in any of
the brain regions (Fig. 2d).
Inhibition of CCR2/5 signaling with cenicriviroc reduces
CNS macrophage infiltration without modulating their
activation state
To investigate the role of IMs that infiltrate into the CNS
after chronic alcohol, we used a small molecule inhibitor,
cenicriviroc (CVC), that blocks the chemokine receptors
CCR2 and CCR5, receptors expressed on monocytes and
macrophages, among other immune cells [16, 21]. Some
mice were fed chronic alcohol and were treated daily with
CVC throughout alcohol exposure for a total of 6weeks of
treatment (6wk CVC), while other mice fed chronic alcohol
were only treated with CVC for the final 3 weeks (3wk
CVC), mimicking a clinical treatment paradigm where treat-
ment often begins only after exposure has occurred (Fig. 3a).
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Pair-fed and alcohol-fed mice received daily vehicle control
injections. Alcohol significantly increased CD11b+CD45hi
IMs compared to pair-fed controls (Fig. 3b). Both 6wk CVC
and 3wk CVC treatment paradigms abrogated the alcohol-
induced infiltration of CD11b+CD45hi IMs, significantly re-
ducing IMs to the level of pair-fed mice (Fig. 3b, c).
Previously, we and others have shown that proinflam-
matory cytokine expression is increased in the brain
after chronic alcohol exposure [12, 13, 22]. Because of
the proinflammatory environment in the CNS induced
by alcohol consumption, we hypothesized that macro-
phages may have altered the expression of surface activa-
tion markers. Using flow cytometry of isolated CNS
immune cells from the total brain, we observed that al-
cohol modestly altered the expression of multiple inves-
tigated activation markers of the CD11b+CD45hi
macrophages, including CD86, CD68, MHC-II, CD163,
and CD206 (Fig. 3d). The expression of these markers
was not significantly changed on CNS IMs, although an
increasing trend was observed for CD86 and a
Fig. 1 Alcohol induces infiltration of peripheral macrophages into the CNS. a Alcohol-fed mice received 5% (v/v) alcohol in Lieber-DeCarli liquid
diet ad libitum (EtOH) for 6 weeks while pair-fed animals received a calorie-matched liquid diet (PF). b mRNA expression of Ccl2, Ccr2, and Ccr5
was measured from the hippocampus of PF and EtOH mice. c Brain immune cells from wild-type mice fed chronic alcohol (EtOH) or a pair-fed
(PF) control diet were isolated and quantified by flow cytometry gating for live, single cells. Microglia (CD11b+ CD45lo) were differentiated from
peripheral macrophages (CD11b+ CD45hi) based on surface marker staining and infiltrating macrophages in pair- vs alcohol-fed mice. d
Quantification of microglia (CD11b+ CD45lo) and peripheral macrophages (CD11b+ CD45hi) in PF and EtOH mice. Data are mean ± SEM, n = 4–7
mice/group. *p < 0.05 by Student’s t test
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decreasing trend for CD163. CVC treatment did not sig-
nificantly alter the expression of these markers on
CD11b+CD45hi macrophages (Fig. 3d), suggesting that
the activation state of IMs in the CNS in alcohol-fed
mice is independent of CCR2/5 signaling.
Chronic alcohol induces inflammatory protein and gene
expression changes
We measured protein levels of proinflammatory cyto-
kines including TNFα, IL-1β, and IL-6 in the hippocam-
pus, where we had observed a significant increase in
CCR2+ macrophages following chronic alcohol. We
found that both TNFα and IL-1β (including both cleaved
and uncleaved forms) were induced by chronic alcohol
and that 3-week treatment with CVC reduced these pro-
teins as well as IL-6 in CVC-treated alcohol-fed mice
(Fig. 4a).
To further probe the expression of proinflammatory
cytokines and related immune genes, we used the Nano-
string Inflammation Panel to screen mRNA levels of 254
inflammation-related genes. In this screen, we found 17
immune-related genes that were significantly altered in
the cerebellum (Fig. 4b). We followed this screen with
qPCR quantification of these gene targets as well as
other selected proinflammatory targets and chemokine
ligands and receptors associated with CCR2/5 signaling
(Fig. 4c). Including more samples as well as samples
from mice treated with CVC, we found that gene expres-
sion was significantly altered in the hippocampus, cortex,
and cerebellum and that CVC treatment corrected some
of these alterations (Fig. 4c). Prominently, we observed
an upregulation in the CCR2/5 signaling pathway in
alcohol-fed mice in the hippocampus that was signifi-
cantly decreased by CVC treatment in both paradigms
(Fig. 4c, Table 4). Interestingly, the most significant ef-
fect of ethanol on gene expression among all inflamma-
tory markers measured was found in the hippocampus,
where we also observed the most infiltration of CCR2+
peripheral macrophages. Tables 3, 4, and 5 provide the
mean and standard deviation for each gene and group in
Fig. 2 Alcohol-induced peripheral macrophages differentially infiltrate the CNS. a CX3CR1eGFP/+ CCR2RFP/+ mice were generated by crossing
CX3CR1eGFP/eGFP CCR2+/+ and CX3CR1+/+ CCR2RFP/RFP mice to allow visualization of resident microglia (GFP+; green) and brain infiltrating
macrophages (RFP+; red) in the cortex, cerebellum, and hippocampus of mice fed chronic alcohol or a calorie-matched diet. b Acquired × 10
images of ethanol-fed CX3CR1eGFP/+ CCR2RFP/+ mice were stitched together to provide the larger representative images shown. c, d
Quantification of resident CX3CR1-eGFP+ microglia and CCR2-RFP+ brain infiltrating macrophages in the cortex, cerebellum, and hippocampus.
Data are mean ± SEM, n = 4–7 mice/group. *p < 0.05; n.s., not significant by Student’s t test
Lowe et al. Journal of Neuroinflammation          (2020) 17:296 Page 7 of 18
the cortex, hippocampus, and cerebellum as well as p
value comparisons between pair- and alcohol-fed mice
(PF vs EtOH) as well as alcohol-fed and CVC-treated
alcohol-fed mice (EtOH vs 6wk CVC; EtOH vs 3wk
CVC). Significant differences are denoted with an aster-
isk (*) and are offset in the column (Tables 3, 4, and 5).
Alcohol induces morphologic changes and alters
expression of activation markers in microglia that are
partially restored by CCR2/5 inhibition
Activated microglia often assume an amoeboid morph-
ology that is characterized by shortened cell processes
and an enlarged soma. We used immunofluorescent
staining of the microglial marker IBA1 to investigate if
chronic alcohol induces morphological changes in line
with an activated cell shape (Fig. 5a). We focused on
hippocampal microglia specifically because of the signifi-
cant infiltration of peripheral CCR2RFP macrophages to
this region (Fig. 2c) suggested this as a site of active neu-
roinflammation. We found that chronic alcohol tended
to increase the cell soma size of microglia (Fig. 5b). Inhi-
biting CCR2/5 signaling with CVC significantly reduced
the soma in chronic alcohol-fed mice with 3 weeks of
CVC treatment (Fig. 5b). Chronic alcohol significantly
Fig. 3 Inhibition of CCR2/5 signaling reduces CNS macrophage infiltration without altering activation marker expression of infiltrating
macrophages. a Mice received a pair-fed diet (PF) or chronic alcohol (EtOH), and some alcohol-fed mice received 6 weeks of daily preventive
subcutaneous CVC injection (EtOH + 6wk CVC) or 3 weeks of daily CVC treatment (EtOH + 3wk CVC). PF and EtOH mice received daily vehicle
control injections. b Representative flow cytometry plots of peripheral macrophages (CD11b+ CD45hi) in EtOH, EtOH + 6wk CVC and EtOH + 3wk
CVC-treated mice. c Quantification of infiltrating brain macrophages (CD11b+ CD45hi) in pair-fed, alcohol-fed, and treatment groups. d Expression
of various activation markers were measured by flow cytometry in CD11b+ CD45hi infiltrating macrophages including CD86, CD68, MHC-II, CD163,
and CD206. Data are mean ± SEM, n = 6–7 mice/group. *p < 0.05 by one-way ANOVA
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reduced the process length of hippocampal microglia,
and CVC administration did not affect this morphology
compared to chronic alcohol-fed mice (Fig. 5c). These
data indicate that chronic alcohol induces a more react-
ive cell morphology than in pair-fed control mice and
CCR2/5 inhibition modestly restores a normal cell body.
To evaluate the activation state of microglia by alcohol
in the CNS, we measured the levels of CD86, CD68,
MHC-II, CD163, and CD206 by flow cytometry in iso-
lated CD11b+CD45lo cells from the total brain. CD68 ex-
pression was downregulated in microglia following
alcohol consumption, while the remainder of the activa-
tion markers were not significantly altered, although
both CD86 and CD163 showed a trend toward increased
expression in alcohol-fed mice. However, CVC treat-
ment increased both CD86 and CD68 in both treatment
paradigms and reduced expression of MHC-II and
CD163 (Fig. 5d), suggesting that CCR2/5 signaling may
contribute to microglia activation in alcohol-fed mice.
CD68 expression is decreased by chronic alcohol
CD68 is a lysosomal protein that is often used as a
marker of phagocytosis in macrophages and particularly
microglia [23, 24]. We hypothesized that ethanol con-
sumption not only alters microglia morphology but also
its phagocytic activity in the hippocampus. Microglial
CD68 levels were measured by immunofluorescence,
which demonstrated a decrease in the hippocampus (in-
cluding CA1, CA3, and dentate gyrus (DG) regions) of
alcohol-fed compared to pair-fed mice (Fig. 6a, b). This
observation was corroborated by flow cytometric ana-
lysis of isolated microglia in which we also observed a
decrease in microglial CD68 positivity in alcohol-fed
mice (Fig. 6c). Interestingly, treatment with CVC did not
affect microglial CD68 expression (measured as
Fig. 4 Chronic alcohol induces inflammatory gene expression changes in multiple brain regions. a Proinflammatory cytokine proteins TNFα, IL-1β,
and IL-6 were measured from the hippocampus of pair- (PF) and alcohol-fed (EtOH) as well as alcohol-fed mice treated with CVC for 3 weeks
(EtOH +3wk CVC) by ELISA. b Inflammatory gene expression of pair- and alcohol-fed mice was analyzed using the Nanostring nCounter
Immunology Panel and revealed 17 genes significantly altered in the cerebellum (green, expression increased; red, expression decreased). c Gene
expression changes of genes found by Nanostring to be altered as well as some common inflammatory markers, and CCR2/5 axis genes were
measured in the hippocampus, cortex, and cerebellum by qPCR in a larger cohort of pair- and alcohol-fed mice as well as mice treated with 3 or
6 weeks CVC (purple, > 3-fold increase in expression; cyan > 3-fold decrease in the expression compared to PF; complete gene expression profile
data found in Tables 3, 4, and 5). Data are mean ± SEM, n = 4–6 mice/group. *p < 0.05 by one-way ANOVA
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colocalization of CD68 and the microglial marker IBA1)
except in the CA3 region of the hippocampus where
CVC decreased CD68 expression (Fig. 6b). However,
flow cytometry measurements of CD68+ microglia re-
vealed an effect of CVC treatment as both inhibitor
treatment paradigms increased CD68 positivity (Fig. 6c).
Importantly, the flow cytometry is based on microglia from
the total brain, whereas the immunofluorescence measure-
ments were performed in the hippocampus only. Taken to-
gether, these data suggest that alcohol significantly reduces
microglial CD68 expression and provides evidence of alter-
ations in the microglial phagocytic activity that may impact
microglia function after chronic alcohol exposure.
CVC administration does not affect alcohol consumption
or preference
The Lieber-DeCarli alcohol delivery model relies on al-
cohol dissolved in a liquid diet to ensure mice receive
sufficient daily alcohol for study purposes. Because the
alcohol is dissolved in the animals’ only source of calo-
ries, there is limited expected variation in alcohol con-
sumption across the groups. Indeed, treatments with
CVC did not significantly alter the daily liquid diet con-
sumption compared with vehicle-treated controls. The
average daily consumption of 5% ethanol in the Lieber-
DeCarli liquid diet for vehicle-treated mice was 18.73 ±
4.0 mL compared with 6wk CVC-treated mice 19.37 ±
Table 3 Gene expression profile of the cortex
Cortex




Mean Stdev Mean Stdev p value Mean Stdev p value Mean Stdev
Nanostring
C1qa 1.021 0.242 1.472 0.519 0.089 0.751 0.185 *0.012 0.750 0.265 *0.015
C1qb 1.015 0.196 1.016 0.292 0.996 0.959 0.272 0.797 0.882 0.243 0.426
Ccl11 1.156 0.743 14.52 12.66 0.073 4.626 3.510 *0.036 3.333 3.057 0.062
Daxx 1.020 0.219 1.331 0.303 0.080 0.751 0.108 *< 0.001 0.890 0.294 *0.038
Gnas 1.017 0.218 1.167 0.279 0.342 0.734 0.068 *< 0.01 0.687 0.173 *< 0.01
Hmgn1 1.004 0.099 1.167 0.307 0.247 1.086 0.157 0.508 0.960 0.244 0.243
Hspb1 1.017 0.204 1.275 0.143 *0.042 1.034 0.238 0.124 0.937 0.237 *0.021
Il23 1.584 1.547 0.926 0.657 0.401 2.484 2.326 0.222 2.430 0.941 *0.015
Itgb2 1.103 0.498 0.833 0.447 0.394 0.384 0.203 0.123 0.726 0.621 0.771
Map3k9 1.068 0.459 0.825 0.422 0.389 0.645 0.427 0.433 0.576 0.180 0.219
Mapk1 1.075 0.499 1.258 0.269 0.482 0.820 0.397 0.108 0.843 0.267 *0.031
Mef2a 1.019 0.205 0.913 0.210 0.420 1.093 0.384 0.402 1.072 0.391 0.437
Myd88 1.017 0.200 0.968 0.244 0.720 1.096 0.263 0.596 0.931 0.108 0.750
Plcb1 1.002 0.070 0.894 0.188 0.223 0.74 0.090 0.231 0.824 0.126 0.474
Tgfβ1 1.023 0.236 1.474 0.422 0.052 0.839 0.450 *0.038 0.657 0.194 *< 0.01
Proinflammatory
Tnfα 1.135 0.651 2.597 1.694 0.081 2.085 1.196 0.530 0.782 0.796 *0.043
Il1β 1.231 0.757 1.19 0.403 0.916 0.667 0.235 0.061 1.145 0.667 0.899
Il17 1.180 0.696 0.823 0.279 0.312 1.975 0.695 *0.018 1.676 1.170 0.149
Tlr4 1.023 0.236 1.209 0.492 0.430 1.024 0.409 0.678 1.013 0.309 0.439
Cox2 1.010 0.153 1.265 0.229 0.054 1.096 0.317 0.434 1.234 0.139 0.788
Ym1 1.093 0.412 22.40 13.11 *< 0.01 8.849 9.192 *0.013 8.183 7.048 *0.041
CCR2/5 network
Ccl2 1.187 0.633 0.960 0.221 0.524 2.227 0.552 *< 0.01 1.684 1.458 0.364
Ccl3 1.311 0.821 2.090 1.527 0.307 1.909 1.716 0.764 1.549 1.033 0.502
Ccr2 1.065 0.402 0.764 0.165 0.200 1.214 1.718 0.623 1.256 0.564 0.134
Ccr5 1.019 0.223 1.530 0.412 *0.027 1.081 0.378 0.060 1.296 0.518 0.436
Gene expression was measured by qPCR. Data are mean or standard deviation (Stdev), n = 5–6 mice/group
*p < 0.05 and significant p values are offset from non-significant values
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3.6 mL (p = 0.37) and 3wk CVC-treated mice 19.79 ± 3.7
mL (p = 0.13). Therefore, to test whether CVC treatment
could have an impact on alcohol consumption or prefer-
ence, we used a two-bottle choice test model. Mice were
treated with daily i.p. injections of CVC or with an equal
volume of the vehicle and provide access to two bottles,
one with water and the other with increasing concentra-
tions of ethanol over the course of the experiment. We
found that CVC treatment did not change the overall
consumption of ethanol per kilogram body weight (Fig.
S1A, supplementary). CVC treatment also had no signifi-
cant effect on alcohol preference (Fig. S1B, supplemen-
tary) compared to vehicle-treated controls (consumption
interaction F(3, 56) = 0.6927; p = 0.5603 and treatment
groups F(1, 56) = 1.341; p = 0.2518; preference interaction
F(3, 56) = 0.9346; p = 0.4301 and treatment groups F(1,
56) = 1.465; p = 0.2312). The total fluid was also measured
as grams of ethanol and water consumed and normalized
to body weight and was not statistically different between
treated and untreated mice (interaction F(3, 56) = 0.046; p
= 0.9869 and treatment groups F(1, 56) = 3.176; p =
0.0801) (Fig. S1C, supplementary).
Discussion
Previous research has described neuroinflammation associ-
ated with chronic alcohol consumption. We hypothesized
Table 4 Gene expression profile of the hippocampus
Hippocampus




Mean Stdev Mean Stdev p value Mean Stdev p value Mean Stdev
Nanostring
C1qa 1.059 0.351 1.049 0.411 0.966 0.851 0.265 0.344 0.670 0.235 0.078
C1qb 1.009 0.150 1.462 0.147 *< 0.001 1.782 0.459 0.134 1.563 0.265 0.431
Ccl11 1.156 0.743 14.52 12.66 0.073 4.626 3.510 0.095 3.333 3.057 0.062
Daxx 1.029 0.261 0.821 0.398 0.310 0.733 0.217 0.645 0.622 0.253 0.327
Gnas 1.017 0.208 0.585 0.306 *0.017 0.613 0.100 0.834 0.492 0.226 0.563
Hmgn1 1.017 0.213 1.482 0.333 *0.016 1.302 0.213 0.291 1.485 0.645 0.993
Hspb1 1.044 0.322 1.357 0.432 0.185 1.274 0.278 0.703 1.013 0.283 0.134
Il23 1.804 1.911 10.62 5.981 *< 0.01 3.780 4.233 *0.045 3.099 3.019 *0.020
Itgb2 1.225 0.749 0.632 0.254 0.097 1.340 0.601 *0.024 0.913 0.471 0.227
Map3k9 1.073 0.414 2.298 1.428 0.071 1.533 0.443 0.239 1.079 0.293 0.068
Mapk1 1.087 0.409 1.033 0.242 0.785 1.041 0.570 0.976 0.887 0.251 0.329
Mef2a 1.022 0.233 1.636 0.702 0.070 1.577 0.183 0.846 1.784 0.349 0.653
Myd88 1.029 0.263 1.379 0.285 0.052 1.222 0.272 0.354 1.022 0.209 *0.033
Plcb1 1.087 0.438 1.685 0.307 *0.021 1.724 0.328 0.837 1.742 0.191 0.708
Tgfβ1 1.039 0.302 0.946 0.344 0.630 0.982 0.342 0.858 0.488 0.312 *0.036
Proinflammatory
Tnfα 1.246 0.651 2.206 1.911 0.291 1.490 0.665 0.407 1.383 1.214 0.394
Il1β 2.320 0.757 2.587 1.707 0.853 1.622 0.811 0.239 1.570 0.866 0.222
Il17 1.069 0.696 1.017 0.534 0.859 1.652 0.745 0.121 1.213 0.769 0.620
Tlr4 1.047 0.236 1.772 0.856 0.083 1.773 0.891 0.999 1.496 0.728 0.562
Cox2 1.007 0.153 1.011 0.168 0.970 1.275 0.231 *0.047 1.325 0.257 *0.031
Ym1 1.093 0.412 22.40 13.11 *< 0.01 8.849 9.192 0.084 8.183 7.048 *0.041
CCR2/5 network
Ccl2 1.051 0.633 3.926 2.837 *0.034 3.858 2.162 0.963 1.451 1.033 0.072
Ccl3 1.301 0.821 6.713 3.069 *< 0.01 2.188 1.338 *< 0.01 2.737 2.238 *0.035
Ccr2 1.024 0.402 11.67 6.247 *0.010 3.958 3.253 *0.035 2.955 2.310 *< 0.01
Ccr5 1.024 0.223 3.433 1.685 *< 0.01 1.659 0.404 *0.031 2.267 0.733 0.151
Gene expression was measured by qPCR. Data are mean or standard deviation (Stdev), n = 5–6 mice/group
*p < 0.05 and significant p values are offset from non-significant values
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that alcohol could induce macrophage infiltration into the
brain and that this infiltration could drive the neuroinflam-
mation observed after chronic alcohol. We therefore tested
if blockade using a CCR2/5 dual inhibitor of the chemokine
network associated with macrophage chemoattraction
could reduce alcohol-induced neuroinflammation. Here, we
show that chronic alcohol induces region-specific infiltra-
tion of IMs into the CNS that is associated with cytokine
expression and microglial activation. Inhibition of CCR2/5
signaling using the small molecule inhibitor CVC abrogated
the infiltration of macrophages, reduced cytokine expres-
sion, and partially normalized microglial morphology.
Although the CNS was long considered an immune-
privileged compartment, an appreciation for peripheral
immune infiltration in the setting of diseases has been ac-
cepted. Only recently has infiltration of peripheral macro-
phages been described in the setting of alcohol-induced
neuroinflammation [11, 22]. Using a different alcohol
model than previously studied in mice, we confirm this
observation using flow cytometry of total immune cells in
the brain, detecting an increase in CD11b+CD45hi macro-
phages. Peripheral macrophages have previously been dis-
tinguished from microglia (CD11b+CD45lo), and although
expression of CD45 can shift during inflammation, gene
expression studies suggest its expression level remains a
distinguishing feature between the two cell types [25].
Additionally, we created CX3CR1eGFP/+ CCR2RFP/+ mice
to allow for visualization and localization of infiltrating
CCR2+ macrophages. While we observed a trend toward
increased macrophages in the cortex and cerebellum, the
largest alcohol-induced increase observed was in the
hippocampus, a region of significant alcohol-related in-
flammation in both rodents and humans [8, 26, 27]. These
data suggest that alcohol-induced macrophage infiltration
Table 5 Gene expression profile of the cerebellum
Cerebellum




Mean Stdev Mean Stdev p value Mean Stdev p value Mean Stdev
Nanostring
C1qa 1.079 0.47 2.788 1.243 *0.010 1.942 0.872 0.202 1.266 0.786 *0.030
C1qb 1.012 0.161 1.017 0.397 0.976 0.773 0.275 0.244 1.165 0.264 0.466
Ccl11 1.043 0.326 37.22 36.99 0.060 16.70 26.98 0.315 6.682 12.75 0.119
Daxx 1.015 0.182 0.972 0.265 0.750 1.132 0.524 0.519 0.704 0.214 0.083
Gnas 1.014 0.198 0.713 0.401 0.130 0.842 0.269 0.528 0.611 0.160 0.577
Hmgn1 1.196 0.977 2.302 1.353 0.136 1.531 0.486 0.219 1.183 1.154 0.155
Hspb1 1.167 0.733 2.995 1.489 *0.022 1.916 0.724 0.141 1.007 0.683 *0.014
Il23 1.277 1.110 2.449 1.791 0.203 2.278 0.849 0.836 1.032 1.011 0.122
Itgb2 1.034 0.286 2.150 1.830 0.169 1.024 0.868 0.221 1.501 1.000 0.516
Map3k9 1.220 0.987 3.344 2.486 0.080 2.916 1.733 0.736 1.033 1.249 0.069
Mapk1 1.462 1.768 1.327 0.595 0.862 1.257 0.473 0.826 1.644 1.290 0.602
Mef2a 1.094 0.584 1.249 0.160 0.544 1.232 0.317 0.906 0.715 0.525 *0.039
Myd88 1.072 0.470 1.020 0.538 0.863 1.398 0.607 0.281 1.358 0.222 0.186
Plcb1 1.004 0.098 0.995 0.390 0.955 1.324 0.370 0.164 1.313 0.337 0.161
Tgfβ1 1.027 0.257 0.997 0.641 0.918 0.697 0.466 0.376 0.698 0.363 0.343
Proinflammatory
Tlr4 1.151 0.368 1.813 1.143 0.207 1.164 0.450 0.225 1.406 0.710 0.477
Cox2 1.028 0.270 1.116 0.319 0.620 1.311 0.350 0.336 1.646 0.638 0.099
Ym1 2.022 2.479 3.953 4.398 0.371 3.755 6.046 0.951 3.598 2.942 0.873
CCR2/5 network
Ccl2 1.087 0.471 7.654 6.998 0.068 3.831 2.432 0.235 3.102 3.328 0.181
Ccl3 1.643 1.988 4.614 4.774 0.229 1.042 1.473 0.145 1.452 1.565 0.193
Ccr2 1.047 0.384 21.35 24.06 0.096 10.48 13.49 0.368 4.777 8.151 0.234
Ccr5 1.039 0.280 2.190 0.530 *< 0.001 1.185 0.524 *< 0.01 1.819 1.235 0.514
Gene expression was measured by qPCR. Data are mean or standard deviation (Stdev), n = 5–6 mice/group
*p < 0.05 and significant p values are offset from non-significant values
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into the CNS may be region-specific and possibly linked
to localized neural damage and immune signaling.
Blockade of CCR2/5 signaling with CVC successfully
limited the alcohol-induced infiltration of peripheral
macrophages into the CNS. Previously, CVC was shown
to be effective at limiting macrophage chemotaxis to the
liver in a model of fibrosis [16]. While successful inhib-
ition of peripheral immune cell infiltration is consistent
with blockade of a chemokine receptor, blocking CCL2
signaling has additional advantages. In the CNS of CCL2
knockout mice, production of proinflammatory cyto-
kines TNFα and IL-1β was significantly reduced after
peripheral injection of bacterial endotoxin (lipopolysac-
charide (LPS)) [28]. Interestingly, these proinflammatory
cytokines were expressed even before peripheral cell in-
filtration occurred, suggesting that, at least in this model,
neuroinflammatory gene expression preceded the re-
sponse of the peripheral immune system. This has im-
portant implications for our present study, as it suggests
that continued proinflammatory signaling within the
CNS depends on chemoattraction of peripheral immune
cells such as monocytes, which is inhibited by the small
molecule CVC. Reducing inflammatory signaling in the
CNS, which in the case of LPS precedes immune cell in-
filtration, may contribute to the reduced expression of
chemokines. Cell-specific knockout of CCR2 (such as
using LysM-driven knockout in peripheral macrophages
or CX3CR1-driven knockout in microglia, for example)
could help to elucidate the importance of peripheral
blockade of CCR2 vs central signaling.
Additionally, recent evidence suggests that, in the devel-
oping brain, mice deficient in either CCL2 or CCR2 are
protected from alcohol-induced neuroinflammation (in-
cluding proinflammatory cytokine expression and micro-
glial activation) and neurotoxicity when treated with an
acute alcohol exposure at postnatal day 4 [29]. These results
agree with the present data, which importantly is from adult
mice with chronic alcohol consumption and provide further
evidence for the importance of CCL2/CCR2 signaling in
alcohol-induced neuroinflammation. Further experiments,
Fig. 5 Alcohol-induced morphologic changes in microglia are partially restored by CCR2/5 inhibition. a Representative images of hippocampal
microglia (CX3CR1-GFP+; green) displaying altered morphologies in pair-fed (PF) vs alcohol-fed (EtOH) mice, acquired at × 63 magnification. b
Quantification of average hippocampal microglia soma area (pixel2) and c perimeter distance (pixel length) in mice fed control or alcohol diet or
alcohol-fed mice treated with CCR2/5 inhibitor. d Expression of various activation markers were measured by flow cytometry in CD11b+ CD45lo
microglia including CD86, CD68, MHC-II, CD163, and CD206. Data are mean ± SEM, n = 3 mice/group and 3–10 sections/mouse for a–c and n =
6–7 mice/group for d. *p < 0.05 by one-way ANOVA.
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including using CCL2 and CCR2 knockout adult mice
under chronic alcohol conditions will also be informative.
Interestingly, we observed the most pronounced alter-
ations in the surface activation markers between micro-
glia of alcohol-fed mice and microglia from mice treated
with CVC. It is important to note that for flow cytomet-
ric analysis for surface marker expression, we used total
brain microglia and infiltrating macrophages, whereas
other assays (such as histology and biochemical mea-
surements) used more localized populations or tissues
for analysis. Therefore, cell surface marker analysis may
not fully reflect the micromilieu within subregions of the
brain. A possible explanation for the alterations in
microglial surface markers is that in the absence of IMs,
the remaining microglia are forced to assume a more ac-
tivated phenotype and respond to the damage induced
by alcohol. Interestingly, while we observed surface pro-
tein activation markers in microglia, we also observed an
activated morphologic phenotype with increased soma
size and reduced microglial cell process length. For this
analysis, we focused on microglia in the hippocampus,
the site of significant peripheral macrophage infiltration
(Fig. 2c) and an increase in protein and mRNA expres-
sion of proinflammatory cytokines (Fig. 4). Microglial
Fig. 6 Alcohol downregulates the microglial expression of CD68. a Representative images of the hippocampal sections stained for Iba1 (green),
CD68 (red), and DAPI (blue) from pair-fed (PF), alcohol-fed (EtOH), and CVC-treated alcohol-fed mice, acquired at × 63 magnification. b
Quantification of Iba1 and CD68 colocalization, normalized to total Iba1+ area per image in the hippocampal CA1, CA3, and DG regions and
throughout the HPF. c Flow cytometry data showing the percent of microglia (defined as CD11b+ CD45lo) that are positive for CD68 expression.
Data are mean ± SEM, n = 3–4 mice/group with 4–5 images per region per mouse. *p < 0.05; n.s., not significant by one-way ANOVA
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morphology is one indicator of an inflammatory milieu, as
these cells change their shape in response to immune acti-
vation, and our flow cytometry data suggested that micro-
glia are significantly affected by alcohol and CVC
administration (Fig. 5). CVC treatment partially rescued
microglial morphology. Compared with alcohol-fed un-
treated mice, the CVC treatment groups had slightly lar-
ger cell bodies but retained the shortened cell process
phenotype of alcohol-fed mice. This mixed microglial
phenotype, despite the absence of IM infiltration, likely
represents the innate response of microglia to alcohol
which is characterized by activation and production of
proinflammatory cytokines and reactive oxygen species
[30–32]. The imaging in Fig. 5 suggests that microglial
morphology was altered by chronic alcohol exposure al-
though histologic examination of the complete microglial
architecture is technically limited as some microglial pro-
cesses may be disrupted by the histologic preparation.
Additional studies have shown that alcohol consumption
may only lead to partial microglia activation [33–35], simi-
lar to the findings we present here (Fig. 5a, b). Therefore,
we examine the microglial morphologic changes in the
context of other measures of a neuroinflammatory milieu
including analysis of activation markers and proinflamma-
tory gene expression.
Chronic alcohol exposure induces a complex, multi-
organ response with activation of a variety of immune
responses and inflammatory expression. Previous re-
search has sought to characterize the gene expression
changes caused by chronic alcohol in various parts of
the brain. Gene expression analyses in humans [36–
39] and rodents [40] reveal alterations in genes related
to neurons and neurogenesis, axonal growth, myelin
regulation, intracellular signaling, protein trafficking,
and other critical cell processes. Interestingly, neu-
roimmune genes were significantly increased in the
frontal cortex of human patients with alcohol use dis-
order [38], while PET studies using markers of glial
density have revealed that alcohol reduces or alters
the behavior of CNS glia, likely representing changes
in the local neuroimmune milieu [41–43]. Using a tar-
geted screen, we observed alterations in inflammation-
related transcripts in the CNS after chronic alcohol in
mice and expanded our focus to investigate the hippo-
campus, cortex, and cerebellum. We observed the up-
regulation of multiple proinflammatory genes similar
to previous descriptions, and some of these were al-
tered by the treatment of CVC to block CCR2/5 sig-
naling. As noted previously, some cytokine expression
is increased prior to the infiltration of peripheral im-
mune cells in other neuroinflammation models [28],
which may provide an explanation for why CVC treat-
ment only altered the expression of some inflamma-
tory genes in the brain regions investigated.
Our data suggest that infiltrating macrophages specif-
ically target the hippocampus as a site of increased infil-
tration. The hippocampus is a critical center for learning
and memory and has been implicated in the pathology
associated with AUD for decades, and this increased per-
ipheral immune cell infiltration may, in part, underline
this regional vulnerability. Hippocampal volume loss is
associated with alcohol consumption in a dose-
dependent manner. In a recently published study, re-
searchers followed individuals for over three decades
and show that increasing amounts of alcohol consump-
tion are associated with a greater risk of hippocampal at-
rophy [3]. Alcohol also influences key processes in
memory formation and learning by suppressing long-
term potentiation (LTP) of synaptic connections [44–46]
and altering proper maturation and maintenance of den-
dritic spines and synaptic connections within the hippo-
campus [47, 48].
Microglia play a critical role in the synaptic pruning
process [23], and alterations in their normal function
have been shown to disrupt proper developmental syn-
aptic pruning [49]. In our study, alcohol consumption
led to morphologic changes in microglia and changes in
surface marker expression (Fig. 5). Also, the lysosomal
protein CD68 was downregulated in the hippocampal
microglia. Thus, the effect of alcohol on microglia is sig-
nificant and may lead to altered microglial phagocytic
function. An interesting future direction would be to as-
sess synaptic pruning in this model. There is also evi-
dence that proinflammatory cytokines may have an
influence on synapse function, much like complement
involvement in the regulation of synapse development.
For example, TNFα has been shown to modulate glu-
tamate receptors and decrease synaptic strength [50–
52]. Interestingly, while the resident source is likely from
the microglia, peripheral macrophages also express
TNFα and may be involved in influencing synapses in
addition to their possible role promoting neuroinflam-
mation [52, 53]. Additionally, we noted increased cyto-
kine protein expression in the hippocampus (Fig. 4), and
cytokines have been implicated in synapse dysregulation
in hippocampus neurons in vitro [54]. Alcohol con-
sumption may therefore be inducing microglial activa-
tion and changes in cytokine production that could
affect the synapse structure function as well as the re-
sponsiveness of microglia to CNS immune surveillance
and pathogen defense.
Previously, we have used various inhibitors of the pro-
inflammatory NLRP3 inflammasome to show that reduc-
tion in inflammation via small molecule inhibitors may
affect alcohol consumption and preference. Using thera-
peutic treatments to inhibit NLRP3, caspase-1, and IL-
1β, we found a reduction in ethanol consumption and
preference in a two-bottle choice test [18]. Thus, in the
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treatment of alcohol-related pathology such as alco-
holic liver disease, some therapeutics may operate via
a mechanism that includes reduced alcohol consump-
tion. Using the two-bottle choice paradigm, we found
that CVC treatment did not influence ethanol con-
sumption or preference. Additionally, using the
Lieber-DeCarli chronic alcohol consumption model,
we observed no difference in alcohol consumption be-
tween control and CVC-treated mice. Therefore, we
can conclude that the data presented here, which in-
cluded a reduction of both peripheral macrophage in-
filtration to the CNS and markers of inflammation
within the CNS parenchyma, is likely due to the dir-
ect effects of CVC blockade on the CCR2/5 receptors
and is not related to a change in the amount of alco-
hol consumed and/or a preference for alcohol. This is
consistent with our previous findings that CVC both
prevented and ameliorated alcoholic liver disease in
mice [55].
Interestingly, previous behavioral studies by Bled-
nov et al. have shown that CCR2-knockout mice
have reduced preference and consumption of etha-
nol, while CCR5-knockout mice increase their con-
sumption and preference compared with wild-type
mice [5]. CVC acts as a dual inhibitor blocking both
the CCR2 and CCR5 receptors. Therefore, our obser-
vation of no change in consumption or preference in
CVC-treated mice may be explained by the previous
observations that CCR2 and CCR5 genetic deficien-
cies have opposite effects on alcohol use or prefer-
ence. Using a dual inhibitor, we may have negated
any effect on ethanol-seeking behavior and thus iso-
lated a direct biologic effect of the CVC molecule on
the underlying biologic pathology associated with al-
cohol use rather than influencing behavior and etha-
nol exposure.
Inflammatory processes in disease states generally
occur as an evolutionary beneficial host response.
However, chronic dysregulated inflammation often
contributes to organ pathology and disease and is a
key feature of chronic alcohol exposure. Infiltrating
macrophages to the CNS in the setting of chronic al-
cohol may be protective or detrimental to the overall
CNS milieu. Whereas we have previously shown that
CVC reduces features of alcoholic liver disease, the
hallmark pathologic features of chronic alcohol on the
CNS are continuing to be defined, especially within
the realm of inflammation, and this present study
stimulates many interesting areas for future research
including on synapse structures and functions, func-
tional connections between glia and neurons, viability
of neurons and glial cells, integrity of the blood-brain
barrier, global neuronal network connections, and
more.
Conclusion
In conclusion, we report here that chronic alcohol in-
duces region-specific infiltration of IMs into the CNS
and that inhibition of CCR2/5 signaling using the small
molecule inhibitor CVC abrogated the infiltration of
macrophages. Chronic alcohol also induced cytokine ex-
pression and microglial activation that was partially nor-
malized by CCR2/5 inhibition. These data provide
critical insights into the role of CCR2/5 signaling, IMs,
and microglia in alcohol-induced neuroinflammation.
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Additional file 1: Figure S1. Ethanol preference and consumption is
unaffected by CVC treatment. Mice were housed singly and received
daily injection of CVC. Two-bottle choice of water or alcohol in drinking
water at increasing concentrations (3, 6, 9, and 12%) for 4 days each was
provided ad libitum. Consumption was measured, and mice were pro-
vided freshwater and alcohol daily. A) The amount of ethanol consumed
at each concentration was normalized to mouse body weight (BW). B) Al-
cohol preference was determined as a ratio of the volume of alcohol
consumed to the total liquid volume consumed per day. C) Total fluid in-
take (water plus alcohol) was measured and normalized to the respective
body weight of each mouse. Data are mean +/- SEM, n = 8 mice/group.
Two-way ANOVA with Bonferroni correction results are described in the
text.
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